贝瑞基因子公司拟对外投资 推进新生儿及儿童基因病一体化检测服务

Group 1 - The core viewpoint of the news is that Berry Genomics is collaborating with Li Wei to establish a joint venture focused on integrated genetic testing services for newborns and children in key regions like Henan [1][4] - The joint venture aims to leverage the expertise of the National Children's Medical Center in the field of genetic disease screening and treatment, creating a model for the prevention of birth defects in China [1][4] - The joint venture will operate in close cooperation with public medical institutions and clinical medical enterprises, enhancing the company's business and generating economic and social benefits [1][4] Group 2 - Berry Genomics has been deeply involved in obstetrics, pediatrics, and genetics, focusing on clinical testing services based on genetic sequencing [2] - The company launched the GENOisi intelligent system in April, which utilizes 15 years of accumulated genetic testing data and self-developed algorithms to support clinical decision-making [2] - Feedback from trial implementations of the GENOisi system in hospitals indicates improved decision-making efficiency for doctors and significantly reduced report generation time [2]